Ampio Pharmaceuticals News

Ampio Pharmaceuticals | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Apr 15 16:20 ET

Ampio Pharmaceuticals | 25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Apr 4 13:35 ET

Ampio Pharmaceuticals | 10-K: FY2023 Annual Report

Mar 27 16:35 ET

Ampio Pharmaceuticals | 8-K: Current report

Mar 25 17:30 ET

Ampio Pharmaceuticals | EFFECT: Others

Mar 5 06:07 ET

Ampio Pharmaceuticals | 8-K: Current report

Feb 28 15:54 ET

Ampio Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Feb 28 15:49 ET

Ampio Pharmaceuticals | S-8 POS: S-8 POS

Feb 28 15:49 ET

Ampio Pharmaceuticals | S-8 POS: S-8 POS

Feb 28 15:49 ET

Ampio Pharmaceuticals | RW: Registration Withdrawal Request

Feb 28 15:48 ET

Ampio Pharmaceuticals | 8-K: Current report

Feb 15 09:37 ET

Ampio Pharmaceuticals | 8-K: Current report

Jan 25 16:36 ET

Ampio Pharmaceuticals | 424B5: Prospectus

Jan 25 16:23 ET

Ampio Pharmaceuticals | 424B5: Prospectus

Jan 24 17:22 ET

Ampio Pharmaceuticals | 8-K: Current report

Jan 11 00:00 ET

Ampio Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933

Dec 21, 2023 16:25 ET

Ampio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bruce E. Terker (1)(0%),Ballyshannon Partners, L.P. ()(0%), etc.

Dec 7, 2023 10:20 ET

Ampio Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

Nov 14, 2023 16:10 ET

Ampio Pharmaceuticals | 8-K: Current report

Nov 2, 2023 09:30 ET

Ampio Pharmaceuticals | 8-K: Current report

Oct 27, 2023 14:10 ET